ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Prostate Cancer Screening: Fostering Informed Decisions

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators: Georgetown University
National Cancer Institute (NCI)
Information provided by: Georgetown University
ClinicalTrials.gov Identifier: NCT00196807
  Purpose

The primary goal of this study is to develop and evaluate a print-based method of patient education with a decision tool that is designed to provide detailed information about prostate cancer and to clarify patient preferences and values, ultimately assisting men in making an informed screening decision.


Condition Intervention Phase
Prostate Cancer
Behavioral: patient decision aid (print-based)
Phase III

MedlinePlus related topics:   Cancer    Prostate Cancer   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Educational/Counseling/Training, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title:   Prostate Cancer Screening: Fostering Informed Decisions

Further study details as provided by Georgetown University:

Primary Outcome Measures:
  • Patient knowledge and decisional satisfaction measured at one month following the intervention.

Secondary Outcome Measures:
  • Decisional conflict measured at one month and the screening decision measured at one year post intervention.

Estimated Enrollment:   600
Study Start Date:   August 2004
Estimated Study Completion Date:   November 2006

Detailed Description:

In spite of the significant disease burden presented by PCa, the utility of screening asymptomatic men remains controversial, as it has not yet been demonstrated by a randomized trial that early diagnosis and treatment of PCa reduces disease-related mortality. The primary goal of the proposed study is neither to encourage nor discourage PCa screening, but to evaluate a method of patient education that is designed to provide detailed screening and treatment-related information and to clarify patient preferences and values, ultimately assisting men in making an informed screening decision. The target population for this educational intervention will be men who have registered to undergo PCa screening within a free, mass screening program. Although at first this may appear to be an atypical group to target for an educational intervention, we present information suggesting that this population represents a large and uniformed group for whom effective and inexpensive methods of education are of critical importance. We will test the impact of providing men with detailed information and a decision aid vs. usual care information and the impact of the timing of administration of information (a week or more prior to the screening vs. usual care, which is on the day of screening). Participants will include men who register for the annual PCa mass screening programs held at Georgetown University and at Howard University during the 2004 and 2005 screening programs. Following enrollment and the baseline interview, participants will be randomly assigned to one of four groups: 1) Information plus Decision Aid received prior to the scheduled screening date (IDA-home); 2) Information plus Decision Aid received on the day of screening (IDA-clinic); 3) Usual Care information received prior to the scheduled screening date (UC-home); or 4) Usual Care information received on the day of the screening (UC-clinic). Follow-up assessments will be conducted post-screening, post receipt of screening results, and one-year post-intervention, to measure knowledge, decisional conflict, decisional satisfaction, and the actual screening decision. We will utilize a 2 (IDA/UC) X 2 (Home/Clinic) X 2 (AA/white) repeated measures analysis of covariance to assess for group differences on these outcomes. If found to be effective, the long-term goal of this research program is to disseminate this informational decision aid for use in mass screening programs.

  Eligibility
Ages Eligible for Study:   50 Years to 70 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Inclusion criteria are: 1) 50-70 years old, 2) English-speaking, and 3) ability to provide meaningful consent.

Exclusion Criteria:

  • The exclusion criteria are: 1) a history of cancer (with the exception of basal cell carcinoma), and 2) a history of prostate disease that has required treatment (e.g., benign prostatic hypertrophy).
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00196807

Locations
United States, District of Columbia
Georgetown University Medical Center    
      Washington, District of Columbia, United States, 20007
Howard University Hospital    
      Washington, District of Columbia, United States, 20060

Sponsors and Collaborators
Georgetown University
National Cancer Institute (NCI)

Investigators
Principal Investigator:     Kathryn L. Taylor, Ph.D.     Georgetown University    
  More Information


Publications:

Study ID Numbers:   R01 CA098967
First Received:   September 12, 2005
Last Updated:   February 22, 2006
ClinicalTrials.gov Identifier:   NCT00196807
Health Authority:   United States: Institutional Review Board

Keywords provided by Georgetown University:
prostate cancer screening  
medical decision making  
informed decision making  
patient education  
male  

Study placed in the following topic categories:
Prostatic Diseases
Genital Neoplasms, Male
Urogenital Neoplasms
Genital Diseases, Male
Prostatic Neoplasms

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on September 23, 2008




Links to all studies - primarily for crawlers